Health
Researchers identify how promising therapy may work to improve adverse effects of NAFLD – News-Medical.Net
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease.
Reviewed by Emily Henderson, B.Sc.Aug 26 2020
A team led by researchers at Massachusetts General Hospital (MGH) has taken an important step forward in the goal of developing a potential treatment for non-alcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. There are currently no approved medications for NAFLD, but in a study published in the journal JCI Insight on August 20, 2020, investigators conducted a genetic analysis that has identified how one promising t…
-
General24 hours agoAustralia’s Myanmar community mourns earthquake losses
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
Noosa News23 hours agoAustralian growers expect to benefit from US tariffs as Trump’s trade war angers markets
-
Noosa News23 hours agoHow to get the most from potted citrus and when they’ll fruit